|
Background
|
ANTXR1 is a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. This protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes.
|
Background
References
|
- Werner,E., J. Biol. Chem. 281 (32), 23227-23236 (2006)
- Wei,W., Cell 124 (6), 1141-1154 (2006)
- Rainey,G.J., Proc. Natl. Acad. Sci. U.S.A. 102 (37), 13278-13283 (2005)
|
Order Information
List Price (USA): $235.00/0.1mg
Related Products
Data Rewards Program
